Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOMUSTINE for Malignant glioma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where LOMUSTINE was used for Malignant glioma.

Most Reported Side Effects for LOMUSTINE

Side Effect Reports % Deaths Hosp.
Death 169 10.5% 165 1
Off label use 135 8.4% 38 33
Thrombocytopenia 127 7.9% 41 54
Disease progression 106 6.6% 28 20
Neutropenia 92 5.7% 40 48
Drug ineffective 88 5.5% 54 26
Fatigue 71 4.4% 10 21
Nausea 68 4.2% 2 20
Platelet count decreased 63 3.9% 2 19
Malignant neoplasm progression 62 3.8% 16 12
Product use in unapproved indication 58 3.6% 11 13
Vomiting 58 3.6% 16 12
Seizure 57 3.5% 11 34
Febrile neutropenia 47 2.9% 9 19
Headache 44 2.7% 17 12

Other Indications for LOMUSTINE

Brain neoplasm malignant (291) Glioblastoma (163) Medulloblastoma (123) Product used for unknown indication (106) Acute myeloid leukaemia (70) Glioma (58) Hodgkin's disease (53) Brain neoplasm (48) Astrocytoma (32) Oligodendroglioma (31)

Other Drugs Used for Malignant glioma

BEVACIZUMAB (230) TEMOZOLOMIDE (206) CARMUSTINE (91) IRINOTECAN (37) PEMBROLIZUMAB (29) GLIADEL (28) CARBOPLATIN (25) NIVOLUMAB (17) ERLOTINIB (16) TEMSIROLIMUS (11)

Related Pages

LOMUSTINE Full Profile All Malignant glioma Drugs LOMUSTINE Demographics LOMUSTINE Timeline